InvestorsHub Logo
Followers 14
Posts 733
Boards Moderated 0
Alias Born 12/09/2013

Re: DewDiligence post# 2558

Tuesday, 05/30/2023 2:39:57 PM

Tuesday, May 30, 2023 2:39:57 PM

Post# of 3015
Yes, I was recently reading on this uptick- interest in how it pertains to ENTA and it's pipeline- and in it's ability to perform trial work.
https://www.forbes.com/sites/brucelee/2023/05/29/human-metapneumovirus-hmpv-has-surged-around-36-higher-in-2023/?sh=f17dc2d71455

Meanwhile in China?
https://www.npr.org/sections/goatsandsoda/2022/12/15/1143002538/china-appears-to-be-facing-what-could-be-the-world-s-largest-coronavirus-outbrea
"COVID spreading faster than ever in China. 800 million could be infected this winter"

I keep hoping that the mechanics of running a Paxlovid non-inferiority study will be rather simple and prescribed. I hope that this translates into action.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News